Senping Cheng

This inventor holds 17 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Triastek, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Senping Cheng. Retrieved from https://idiyas.com/inventor/senping-cheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 12)

% Patents Active = 94.1

CIPO Patents = 2 (Patent Applications = 11)

EPO Patents = 2 (Patent Applications = 17)

Average Co-Inventor Count = 5.7

ph-index = 7

Forward Citations = 126(Granted Patents)

Company Filing History:

17 out of 24

Triastek, Inc.

patents

Years Active: 2019-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12752483 - High-precision additive manufacturing device and high-throughput additive manufacturing system (2026-10-06),

2. 12605881 - 3D printing device and method (2026-04-21),

3. 12595084 - Continuous unloading and packaging system of pharmaceutical additive manufacturing (2026-04-07),

4. 12384112 - High-throughput and high-precision pharmaceutical additive manufacturing system (2025-08-12),

5. 12168538 - Continuous unloading and packaging system of pharmaceutical additive manufacturing (2024-12-17),

6. 12156945 - Precision pharmaceutical 3D printing device (2024-12-03),

7. 12103231 - High-precision additive manufacturing device and high-throughput additive manufacturing system (2024-10-01),

8. 12102721 - Dosage forms of controlled release at specific gastrointestinal sites (2024-10-01),

9. 11612569 - Precision pharmaceutical 3D printing device (2023-03-28),

10. 11571391 - Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant (2023-02-07),

11. 11458684 - High-throughput and high-precision pharmaceutical additive manufacturing system (2022-10-04),

12. 11383439 - High-throughput and high-precision pharmaceutical additive manufacturing system (2022-07-12),

13. 11364674 - 3D printing device and method (2022-06-21),

14. 11292193 - High-throughput and high-precision pharmaceutical additive manufacturing system (2022-04-05),

15. 10624857 - Precision pharmaceutical 3D printing device (2020-04-21),

Title: Innovations of Senping Cheng in Pharmaceutical Additive Manufacturing

Introduction

Senping Cheng is a prominent inventor based in Nanjing, China, known for his significant contributions to the field of pharmaceutical additive manufacturing. With a total of 14 patents to his name, Cheng has been at the forefront of developing innovative technologies that enhance the efficiency and precision of pharmaceutical production.

Latest Patents

Cheng's latest patents include a "High-throughput and high-precision pharmaceutical additive manufacturing system." This invention focuses on utilizing additive manufacturing technology to produce pharmaceutical products. The exemplary printing system features a material supply module, a flow distribution module, and a printing platform designed to optimize the manufacturing process. Another notable patent is the "Continuous unloading and packaging system of pharmaceutical additive manufacturing." This system aims to streamline the unloading, inspection, packaging, and tracing of pharmaceutical units produced by additive manufacturing, ensuring high throughput and efficiency.

Career Highlights

Senping Cheng is currently associated with Triastek, Inc., a company dedicated to advancing additive manufacturing technologies in the pharmaceutical sector. His work has significantly impacted the way pharmaceutical products are manufactured, making processes more efficient and reliable.

Collaborations

Throughout his career, Cheng has collaborated with talented individuals such as Xiaoling Li and Feihuang Deng. These collaborations have fostered innovation and have contributed to the successful development of his patented technologies.

Conclusion

Senping

Profile summary based on public USPTO records.